161 related articles for article (PubMed ID: 35221802)
1. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma.
Luo W; Nagaria TS; Sun H; Ma J; Lombardo JL; Bassett R; Cao AC; Tan D
Pathol Oncol Res; 2022; 28():1610293. PubMed ID: 35221802
[TBL] [Abstract][Full Text] [Related]
2. Expression and Clinical Relevance of SOX9 in Gastric Cancer.
Mesquita P; Freire AF; Lopes N; Gomes R; Azevedo D; Barros R; Pereira B; Cavadas B; Pópulo H; Boaventura P; David L; Pereira L; Almeida R
Dis Markers; 2019; 2019():8267021. PubMed ID: 31275454
[TBL] [Abstract][Full Text] [Related]
3. Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
Link H; Angele M; Schüller M; Ganschow P; Machetanz L; Guba M; Werner J; Kirchner T; Neumann J
BMC Cancer; 2018 Apr; 18(1):483. PubMed ID: 29703178
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of Sry-related High Mobility Group Box 9 and Gastrokine-1 in Gastric Cancer and Their Relationships with Prognosis].
Chen JB; Xu GS; Cai XJ; Liu HT; Sun KL; Luo X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):315-322. PubMed ID: 31282324
[TBL] [Abstract][Full Text] [Related]
5. Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer.
Lee WS; Park YL; Kim N; Oh HH; Son DJ; Kim MY; Oak CY; Chung CY; Park HC; Kim JS; Myung DS; Cho SB; Joo YE
Int J Oncol; 2015 May; 46(5):2154-62. PubMed ID: 25672320
[TBL] [Abstract][Full Text] [Related]
6. SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition.
Chen D; Zhou H; Liu G; Zhao Y; Cao G; Liu Q
J Cell Mol Med; 2018 Feb; 22(2):797-807. PubMed ID: 28940639
[TBL] [Abstract][Full Text] [Related]
7. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract][Full Text] [Related]
8. [Association of SOX9 expression and prognosis in patients with gastric cancer].
Shao CM; Shao QS; Yao HB; Zhao ZK; Xu J; Zhao ZS; Tao HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):736-9. PubMed ID: 22851082
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers.
Choi YJ; Song JH; Yoon JH; Choi WS; Nam SW; Lee JY; Park WS
Gastric Cancer; 2014 Apr; 17(2):247-54. PubMed ID: 23812904
[TBL] [Abstract][Full Text] [Related]
10. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
11. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
12. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
[TBL] [Abstract][Full Text] [Related]
14. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
Fan LC; Jeng YM; Lu YT; Lien HC
PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
Carrasco-Garcia E; Álvarez-Satta M; García-Puga M; Ribeiro ML; Arevalo S; Arauzo-Bravo M; Matheu A
Expert Opin Ther Targets; 2019 Feb; 23(2):143-152. PubMed ID: 30572738
[TBL] [Abstract][Full Text] [Related]
16. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans.
Sashikawa Kimura M; Mutoh H; Sugano K
J Gastroenterol; 2011 Nov; 46(11):1292-9. PubMed ID: 21861142
[TBL] [Abstract][Full Text] [Related]
17. MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9.
Shang JC; Yu GZ; Ji ZW; Wang XQ; Xia L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6160-6169. PubMed ID: 31364116
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions.
Liu JN; Shang Guan YM; Qi YZ; Wang HB; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2012 Aug; 16(4):235-44. PubMed ID: 22209504
[TBL] [Abstract][Full Text] [Related]
19. SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated.
Li G; Chen H; Ren C
Gastroenterology; 2023 Oct; 165(4):1094. PubMed ID: 37414194
[No Abstract] [Full Text] [Related]
20. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Zhao J; Li H; Yuan M
Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
